|
Name: N-Ethylamphetamine
Type: Stimulant
AKA: NEA
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
In 1953, a chemist at the University of Illinois discovered that n-ethylamphetamine (also known as MDMA) had the potential to be an antidepressant. It was found to be an effective treatment for depression and the effects lasted for up to 12 weeks.
The drug was first tested in humans in 1954 and then the FDA approved it for use in 1955.
The drug was first tested in humans in 1954 and then the FDA approved it for use in 1955.
In 1954, a chemist at the University of Illinois discovered that n-ethylamphetamine (also known as MDMA) had the potential to be an antidepressant. It was found to be an effective treatment for depression and the effects lasted for up to 12 weeks.
The drug was first tested in humans in 1954 and then the FDA approved it for use in 1955.
The drug was first tested in humans in 1954 and then the FDA approved it for use in 1955.
In 1954, a chemist at
|
|
V. Legal Information
N-Ethylamphetamine is a stimulant with effects similar to amphetamines. It is controlled in the U.S. under the Federal Analog Act if it mimics controlled substances. Globally, many countries have increased regulation to manage stimulant abuse, reflecting a trend towards stricter control of such substances. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
N-Ethylamphetamine is a stimulant similar to amphetamine. It increases energy, alertness, and euphoria. It can cause dilated pupils, elevated heart rate, and increased blood pressure. Short-term effects include enhanced cognitive and physical performance, while long-term use may result in cardiovascular issues and psychological dependence. Overdose risks include severe agitation and cardiovascular problems. Safe dosing is essential, and recent research focuses on its stimulant effects and potential for abuse.  |
|
VII. Psychological Effects
N/A
 |
|
VIII. Culture
N-Ethylamphetamine is a synthetic stimulant, classifying it as an upper. Short-term use induces increased energy, euphoria, and enhanced alertness, while long-term use can lead to cardiovascular issues and psychological dependence. Overdose risks include severe agitation, cardiovascular problems, and potential for psychosis. Safe dosages are not well-established, with lower doses advised. Recent research emphasizes its stimulant effects and potential for abuse. Physical effects include dilated pupils, increased heart rate, and elevated blood pressure.
 |